ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

31182 results sorted by trial registration date.
  • Technology to stop skin cancer: can new technology improve sun protection behaviours in organ transplant recipients?

    This feasibility study is aiming to test a mobile phone app (called ‘SunVisor’) to determine its effectiveness, particularly in organ transplant recipients. Who is it for? You may be eligible for this study if you are aged 15 or older, are attending the Australian Transplant Games 2018 and have a mobile phone with internet access. Study details All participants will complete a baseline survey, download and install the SunVisor application and receive a tube of sunscreen. Throughout the period of the Transplant Games, participants will use the application at their discretion. After two weeks participants will partake in a 20 minute telephone interview about their experience using the application. It is hoped this research will show this app improves sun protection strategies and reduces sunburn incidence in this vulnerable population.

  • Metformin for treating peripheral artery disease-related walking impairment

  • The effect of fruit anthocyanins in participants attending a cognitive rehabilitation group for mild cognitive impairment: A randomised controlled trial.

    The study aims to evaluate the combined effect of a cognitive rehabilitation group (CRG) with intake of Queen Garnet plum (QGP) juice, to optimise cognition in adults with mild cognitive impairment (MCI). Biomedical measures would contribute to an understanding of the mechanisms of action associated with cognitive improvements. The study would include an 8week, doubleblind randomised controlled trial with two arms, CRG plus placebo, and CRG plus 250mL QGP juice, using MCI patients referred to the ISLHD Geriatric Outpatient Services or Rehabilitation and Medical Psychology Department. Recruitment and research consent of participants will occur within ISLHD clinics, with an aim of 72 subjects. Participants will attend a data collection session at baseline, conducted by Clinical Neuropsychologist and a Research Assistant, where participants will undergo the neuropsychological test battery, collection of demographic data, a food frequency questionnaire and instructions for a 4day food record, and blood collection. Subjects will be provided a 24hour Blood Pressure monitoring device, a urine and faecal sample collection kit, and their supplement/placebo to commence. These assessment procedures will be repeated at 8 weeks.

  • Determination of perioperative levels of cefazolin in paediatric cardiac surgical patients

    The objective of this study was to determine the effect of age, prolonged bypass and deep hypothermia on perioperative levels of cefazolin in children undergoing cardiac surgery.

  • The effects of AD047 and AD282 on obstructive sleep apnoea (OSA)

    The primary goal of this study is to determine the effects of two drug combinations (known as AD047 and AD282) on sleep apnoea severity (the apnoea/hypopnoea index) compared to a placebo (sugar pill). Other measures of sleep apnoea severity, upper airway function, breathing and symptoms will also be assessed as secondary outcomes.

  • Balloon aortic valvuloplasty versus surgical aortic valvuloplasty for congenital aortic valve stenosis.

    Congenital aortic stenosis is a lifelong disease often requiring multiple interventions. Valvuloplasty refers to the procedure by which the valve obstruction is relieved by either incising the valve during a surgical procedure or utilising balloon to stretch the valve during an interventional cardiology procedure. We are seeking to determine the early and late outcomes of surgical or balloon aortic valvuloplasty and whether the technique use, influences the long term risk of re-intervention, other morbidities, or death.

  • Medlab NanoCelle™ D3 hormone blood level absorption study in healthy adult volunteers.

    The study investigates the absorption characteristics and safety of Medlab’s NanoCelle D3 (Vitamin D3 as cholecalciferol) administered to 8 healthy individuals. The dose to be administered in 10 sprays/5000 I.U./1.5mL. A total of four 10 mL blood samples will be collected from each participant at 0, 60, 180 and 360 minutes. The total study duration per participant is approximately 7.5 hours.

  • Mechanisms of Mindfulness Meditation for Experimental Pain

    As many as 1 in 4 Australians experience chronic pain. There is a critical need for the development and evaluation of fast-acting non-pharmaceutical treatments that have the capacity to target the multidimensional nature of chronic pain. This study will compare the effects and mechanisms of mindfulness meditation against placebo and no-treatment control groups. Results will ultimately lead to targeted interventions that more effectively engage cognitive mechanisms associated with pain attenuation.

  • Vitamin D supplementation to prevent acute respiratory infections among Indigenous children in the Northern Territory: a randomised controlled trial

    A double-blind (allocation concealed) randomised controlled trial conducted among Indigenous mother-infant pairs in the Northern Territory. To determine whether weekly vitamin D supplementation (compared to placebo) given to mothers (between 28 to 34 weeks gestation (inclusive) until birth) and their infants (birth until age 4 months) reduces the incidence of acute respiratory infection (hospitalisations or primary care presentations) in the infants first 12 months of life.

  • Understanding how cost, time and support from others influence the foods parents choose to give to their child

    Globally children's intake of unhealthy foods and beverages is excessive, contributing to weight gain and risk of obesity. There is a lack of research focusing on unhealthy foods with majority of past research focused on increasing healthy foods in the hope that unhealthy foods will also decrease, which has not been the case (Johnson et al., accepted). Parents play a key role in what children eat (Yee et al. 2017). Understanding the physical and social opportunity influences on parents’ food provision will help to guide future intervention content to support parents to make healthy food choices for their children. This project aims to explore the influence of physical* and social^ opportunity on parents’ unhealthy food provision choices for their 3-7 year old children. The project is focused on understanding the influence of parents’ physical opportunity, in terms of cost and time, and social opportunity, in terms of support from their child, co-parent and friends. The project will also determine whether the influence of physical and social opportunity on parental food provision differs in social occasions. To achieve the project aim a discrete choice experiment will be administered via an online survey to investigate parents’ hypothetical food provision in social and everyday occasions, where the food options vary in terms of the cost, time to prepare, support from child, significant family members and friends, and type of food (nutritional value). The discrete choice experiment contains a number of choice tasks (a type of single-answer question) which involves parents choosing between two hypothetical snack options or the neither (opt-out) option. The two snack options will vary in their attributes (e.g. cost, time, support from child, co-parent and friends, and the type of food). * Physical opportunity = the physical resources a parent has available, such as money (cost) and time. ^ Social opportunity = what is afforded by the social environment, such as support (or resistance/opposition) from the child, co-parent, extended family and friends.

Tags:
  • Finding clinical trials